NYSE:UNH 8 October 2025 - 28 November 2025

UnitedHealth Group Incorporated heads into Friday’s shortened Black Friday session still carrying one of the ugliest year‑to‑date charts in the Dow – and some of the heaviest policy and legal baggage in the U.S. healthcare sector.

UnitedHealth Group Incorporated shares traded higher on Wednesday, November 26, 2025, as Wall Street digested fresh headlines on Medicare commissions, tense hospital contract talks and new institutional trading disclosures. In late trading, UNH was changing hands around $330–331, up about 1.3% on the day, after closing Tuesday at $326.28.INDmoney+2StockInvest+2

As of the latest afternoon trading on November 25, 2025, UnitedHealth shares are changing hands around $327.7, up roughly 2.7% on the session from yesterday’s close near $319.1.Yahoo Finance The stock is helping lift the Dow Jones Industrial Average, even as technology names drag on the broader S&P 500 — MarketWatch specifically notes Merck and UnitedHealth as key supports for the index today.MarketWatch

UnitedHealth Group Incorporated shares are edging higher today as investors digest fresh policy headlines out of Washington and a wave of new analysis explaining how the stock managed to lose roughly half its value over the past year.

UnitedHealth’s volatile 2025 has made UNH a headline story heading into Nov. 3 trading. After a surprise earnings miss in Q1 and a CEO shakeup this spring, UNH plunged to four-year lows. In late Oct. the turnaround narrative got a boost: Q3 beat estimates and management raised guidancegurufocus.comgurufocus.com. CEO Stephen Hemsley told investors he’s confident “we will return to solid earnings growth next year” thanks to “operational rigor and more prudent pricing”reuters.com. Guggenheim and Reuters note Hemsley’s comeback has reassured investors and even prompted Buffett to buy inreuters.comreuters.com.

UnitedHealth’s recent earnings and strategic shifts have drawn close market attention. The company’s Q3 2025 results beat expectations, enabling a tighter outlook. Its revenue for Q3 rose 12% to $113.2 billion unitedhealthgroup.com, with adjusted profit of $2.92 per share. That exceeded estimates and allowed management to raise full-year profit guidance. On Oct. 28, UnitedHealth said it now sees 2025 net EPS of at least $16.25 reuters.com – above the roughly $16.20 analysts had forecast. As portfolio manager Daniel Barasa of Gabelli Funds noted, “the results, the EPS guidance increase, and management commentary were all highly encouraging,” potentially signaling a return to UNH’s pattern of beats and upward revisions reuters.com. CEO Stephen Hemsley echoed confidence, saying the quarter’s execution positions the company for “durable and accelerating growth in 2026 and beyond” unitedhealthgroup.com. Hemsley even called 2026 a “stepping-off point” for UnitedHealth’s turnaround fiercehealthcare.com.

UnitedHealth stock has seen volatile swings in 2025, but recent weeks brought a measure of relief. As of Oct. 21, shares trade around $364, up from the lows hit earlier in the year. On Monday, UNH jumped +2.21% to close at $364.48investing.com, recovering from a mid-month dip. Over the past week the stock oscillated in the mid-$350s to $360s, essentially flat to slightly higher overallinvesting.com.

UnitedHealth Group’s share price has been volatile in 2025. On 8 Oct 2025 the stock closed around $372—IndMoney quoted $372.93 while Investing.com listed $372.64indmoney.cominvesting.com. Reuters reported that the last trade was $371.46, up 2.15 % from the previous dayreuters.com. The wide 52‑week range highlights the enormous drawdown from April’s peak and underscores the severity of the 2025 sell‑off. The stock’s average daily trading volume is about 5.9 million shares, and its beta of 0.47 indicates less volatility than the S&P 500reuters.commarketbeat.com.